DJIA 18,010.68 -115.44 -0.64%
NASDAQ 5,070.03 -27.95 -0.55%
S&P 500 2,107.39 -13.40 -0.63%
market minute promo

GlaxoSmithKline (NYSE: GSK)

company name or ticker
Company Photos
(Click to zoom)

Is AbbVie Inc. Stock About to Crash?

AbbVie has been an amazing growth story since its inception in 2013. However, this trend might be about to come to abrupt end. Here's why.

3 Drugs Stocks Driving The Industry Higher

10 Top Dividend Healthcare Dogs Declare 5% To 20% March Upsides

3 Cheap Dividend Stocks You Can Buy Right Now

If you're on the lookout for cheap dividend stocks, you'll want to know these three names.

Clinical Trial Patients' Positive Experiences Bode Well For Genocea's Billion Dollar HSV Drug

Out of 12 Big Pharma Stocks, This is the 1 You Can Confidently Hold for the Next 10 Years

Big Pharma stocks often have deep product pipelines, substantial cash flow, and healthy dividends, but they are far from created equal. With patent expirations taking their toll, this would appear to be the one Big Pharma stock you can trust over the next decade.

3 Buy-Rated Dividend Stocks Taking The Lead: LAMR, ED, GSK

GSK Makes Notable Cross Below Critical Moving Average

Veeva (VEEV) OpenKey: A Key to Customer Data Referencing - Analyst Blog

Is It Time for GlaxoSmithKline plc to Change Management?

GlaxoSmithKline's share price has stagnated under CEO Andrew Witty. Is it time for a change?